Medical Health & Life Science Research News

Learn details of the Global strategic collaborations in the double barreled antibody industry

Medical Market Research

The Report Double Barreled Antibodies Drugs Market focuses on major leading Market players, Key market segments and sub-segments to provide comprehensive and insightful data

The double barreled or bi-specific antibodies concept is progressively gaining traction in the biopharmaceutical industry owing to several therapeutic advantages, as well as their potential to address challenges being faced with the mAb based therapies. Bi-specific antibodies are artificial antibodies developed by joining together two monoclonal antibodies or their parts that target different epitopes.

The resulting bi-specific antibody has binding affinities for two or three different epitopes concomitantly. 

Explore More Information about report @…elopments/1763032 Make an Inquiry about this news

According to the Research Cosmos report entitled “Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022”, the double barreled antibodies market is anticipated to reach US$ 604.9 Million by 2022.